Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment

doi:10.3748/wjg.v29.i40.5566

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4131)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1642

Figures (1-5)

344

Tables (1-5)

250

Sum=2364

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

238

Download

612

Sum=850

Publishing Process of This Article

Item

Count

Browse

171

Download

610

Sum=781

Oct 28, 2023 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 28, 2023; 29(40): 5566-5581
Published online Oct 28, 2023. doi: 10.3748/wjg.v29.i40.5566

Full Size Figure Download Figure

Figure 5 Kaplan–Meier analysis of cancer-specific survival according to PD-L1 and PD-L2 expression in small bowel adenocarcinoma patients with FoxP3/CD8-low tumors. A: Survival based on PD-L1 combined positive score (CPS) among patients in the FoxP3/CD8-low group; B: Survival based on PD-L2 CPS among patients in the FoxP3/CD8-low group.

Citation: Hoshimoto A, Tatsuguchi A, Hamakubo R, Nishimoto T, Omori J, Akimoto N, Tanaka S, Fujimori S, Hatori T, Shimizu A, Iwakiri K. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment. World J Gastroenterol 2023; 29(40): 5566-5581
URL: https://www.wjgnet.com/1007-9327/full/v29/i40/5566.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i40.5566